AU2022344667A1 - Fibroblast-containing pharmaceutical composition for treating kidney disease - Google Patents

Fibroblast-containing pharmaceutical composition for treating kidney disease Download PDF

Info

Publication number
AU2022344667A1
AU2022344667A1 AU2022344667A AU2022344667A AU2022344667A1 AU 2022344667 A1 AU2022344667 A1 AU 2022344667A1 AU 2022344667 A AU2022344667 A AU 2022344667A AU 2022344667 A AU2022344667 A AU 2022344667A AU 2022344667 A1 AU2022344667 A1 AU 2022344667A1
Authority
AU
Australia
Prior art keywords
fibroblasts
less
cfs
pharmaceutical composition
kidney disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022344667A
Other languages
English (en)
Inventor
Jun HOMMA
Tomomi Imamura
Takahiro IWAMIYA
Yuimi MATSUOKA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lymphogenix Ltd
Original Assignee
Lymphogenix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lymphogenix Ltd filed Critical Lymphogenix Ltd
Publication of AU2022344667A1 publication Critical patent/AU2022344667A1/en
Assigned to LYMPHOGENIX LIMITED reassignment LYMPHOGENIX LIMITED Request for Assignment Assignors: METCELA INC.
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2022344667A 2021-09-08 2022-08-23 Fibroblast-containing pharmaceutical composition for treating kidney disease Pending AU2022344667A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021146130 2021-09-08
JP2021-146130 2021-09-08
PCT/JP2022/031721 WO2023037868A1 (ja) 2021-09-08 2022-08-23 線維芽細胞を含む腎疾患治療用医薬組成物

Publications (1)

Publication Number Publication Date
AU2022344667A1 true AU2022344667A1 (en) 2024-01-25

Family

ID=85506601

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022344667A Pending AU2022344667A1 (en) 2021-09-08 2022-08-23 Fibroblast-containing pharmaceutical composition for treating kidney disease

Country Status (7)

Country Link
US (1) US20240316113A1 (https=)
EP (1) EP4349349A4 (https=)
JP (1) JPWO2023037868A1 (https=)
CN (1) CN117750964A (https=)
AU (1) AU2022344667A1 (https=)
CA (1) CA3226199A1 (https=)
WO (1) WO2023037868A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3211113A1 (en) * 2021-03-04 2022-09-09 Metcela Inc. Lymphangiogenesis promoting factor-expressing fibroblast, and pharmaceutical composition containing same
CN119685401A (zh) * 2024-06-03 2025-03-25 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种改造成纤维细胞的方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102407387B1 (ko) * 2017-02-24 2022-06-10 가부시키가이샤 메토세라 섬유아세포를 포함하고, 심장 질환들의 치료를 위하여 사용될 수 있는 주사용 조성물, 및 치료 용도를 위하여 섬유아세포를 생산하는 방법
CA3110831A1 (en) 2018-08-29 2020-03-05 Metcela Inc. Method for producing fibroblast, and g-csf-positive fibroblast mass
WO2021133790A1 (en) * 2019-12-26 2021-07-01 Figene, Llc Prevention and treatment of kidney failure by administration of fibroblasts and products thereof
CN115210361B (zh) * 2020-03-04 2024-12-10 淋巴奥格尼克斯有限公司 促红细胞生成素产生能力增强的成纤维细胞、制造方法以及医药组合物
CA3211113A1 (en) * 2021-03-04 2022-09-09 Metcela Inc. Lymphangiogenesis promoting factor-expressing fibroblast, and pharmaceutical composition containing same

Also Published As

Publication number Publication date
CN117750964A (zh) 2024-03-22
JPWO2023037868A1 (https=) 2023-03-16
WO2023037868A1 (ja) 2023-03-16
EP4349349A4 (en) 2025-05-21
EP4349349A1 (en) 2024-04-10
US20240316113A1 (en) 2024-09-26
CA3226199A1 (en) 2023-03-16

Similar Documents

Publication Publication Date Title
JP6129418B2 (ja) ヒト胚性幹細胞から由来した間葉系幹細胞を有効成分として含有する肝繊維化または肝硬変予防及び治療用組成物
JP5240715B2 (ja) 脂肪組織由来多分化能幹細胞を含有する細胞製剤
US20140106447A1 (en) Compositions and methods for recruiting stem cells
CN109666629A (zh) 人多能干细胞来源的外泌体、基于该外泌体的制剂及用途
EP4349349A1 (en) Fibroblast-containing pharmaceutical composition for treating kidney disease
Xiang et al. Direct in vivo application of induced pluripotent stem cells is feasible and can be safe
CN113574167A (zh) 利用混合物4f增加干细胞生物学活性的组合物
US20250073278A1 (en) Methods and compositions for treatment of penile defects
KR20190065245A (ko) 만성 신장 질환의 치료를 위한 생체활성 신장 세포
JP2012516853A (ja) 分化した内皮前駆細胞の治療的使用
US20200078409A1 (en) Method for treatment of infertility, pharmaceutical composition for treatment of infertility and method for producing the same
Stenvinkel et al. Implantation of autologous selected renal cells in diabetic chronic kidney disease stages 3 and 4—clinical experience of a “first in human” study
JP7555142B2 (ja) 糖尿病を治療するための幹細胞薬
JP7499853B2 (ja) 誘導万能幹細胞由来間葉幹細胞の前駆細胞に由来するエクソソームを含む腎臓疾患の予防又は治療用組成物
Wada et al. Safety and feasibility of fat injection therapy with adipose-derived stem cells in a rabbit hypoglossal nerve paralysis model: A pilot study
KR20140041263A (ko) 말초혈액 단핵세포를 유효성분으로 포함하는 예방 또는 치료용 약제학적 조성물
WO2018216228A1 (ja) 立体型細胞構造体を用いた尿路組織の再生方法
KR102526447B1 (ko) 편도 유래 중간엽 줄기세포의 조정 배지를 포함하는 간질환 예방 또는 치료용 조성물
KR101789475B1 (ko) 편도 유래 중간엽 줄기세포 또는 이의 조정 배지를 포함하는 골다공증 예방 또는 치료용 조성물
US20210196760A1 (en) Pharmaceutical composition for treating cartilage damage, comprising nasal septum chondrocytes
Gao et al. Ultrasound responsive hydrogel encapsulating engineered exosomes for halofuginone delivery in post-traumatic joint contracture therapy
WO2025258705A1 (ja) 組成物
TWI630913B (zh) Use of a pharmaceutical composition for preparing a medicament for treating acute kidney injury
KR20190049174A (ko) 이식된 지방세포의 생착 증진용 조성물 및 지방 이식용 세포 치료제 조성물
KR20170091882A (ko) 편도 유래 중간엽 줄기세포 또는 이의 조정 배지를 포함하는 골다공증 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: LYMPHOGENIX LIMITED

Free format text: FORMER APPLICANT(S): METCELA INC.